Skip to main content
. 2020 Jan 20;6(2):99–102. doi: 10.1016/j.jdcr.2019.10.010

Table I.

Baseline patient characteristics

Patient 1 Patient 2
Age 26 24
Gender M F
Employment status On disability On disability
Hurley stage III III
Anatomic region Bilateral axillae, abdomen, bilateral inguinal folds Inframammary, abdominal pannus, bilateral inguinal folds, perineum, buttocks, intergluteal cleft, posterior thighs
Appearance >10 draining abscesses and ulcerations 10-20 ulcerations
Comorbidities Anemia of chronic disease, depression, Obesity, paradoxical psoriasis Anemia of chronic disease, diabetes mellitus type II, endometriosis, gastroesophageal reflux disorder, hypothyroidism, migraines, morbid obesity, osteoporosis, Polycystic ovarian syndrome, pyoderma gangrenosum
HS maintenance regimen Tofactinib 5 mg 2x daily; amoxicillin 500 mg 2x daily; cyclosporine 300 mg (∼5 mg/kg) daily Tofacitinib 5 mg 2× daily; 4 week antibiotic cycle of amoxicillin + amoxicllin-clavulanate ×3 weeks and azithromycin ×1 week; 1250 mg MMF 2× daily; triamcinolone ointment
Prior therapies Adalimumab, infliximab, methotrexate, oral amoxicillin, oral amoxicillin-clavulanate, oral doxycycline, oral minocycline, acitretin Adalimumab, etanercept, infliximab, ustekinumab, anakinra, azathioprine, cyclosporine, methotrexate, oral steroids, tacrolimus, oral contraceptive pills